There is a rhetorical trick that powers almost every viral post claiming saturated fat was framed and seed oils are poison. The trick is to take one study, usually old, usually observational, usually from the weakest tier of evidence, and present it as if it overturns everything above it. A 1967 railway survey gets held up against sixty years of randomized trials, genetic studies, and drug trials, and the audience is never told that these things do not sit on the same shelf.

So this post does something the viral posts never do. It walks through every level of the evidence hierarchy, from the bottom rung to the top, and shows what each level actually says about saturated fat, unsaturated plant oils, cardiovascular disease, and type 2 diabetes. Then it lays out where every major scientific body on Earth has landed after reviewing that same evidence. Every claim is referenced at the end.

The short version: the evidence is not close. But the long version is worth reading, because once you understand the structure of the evidence, you can never be fooled by a single cherry-picked study again.

How the hierarchy of evidence works

Why are some nutrition studies stronger than others?

Scientific evidence in nutrition comes in tiers, and the tiers exist because different study designs are vulnerable to different errors.

At the bottom sit mechanistic and animal studies, which tell you what is biologically plausible. Above them sit ecological studies, which compare whole populations and cannot separate diet from the hundred other ways populations differ. Above those sit prospective cohort studies, which follow individuals for decades and can adjust for confounders but cannot fully eliminate them. Above those sit randomized controlled trials, the only design that can isolate cause and effect in humans. Alongside and above the trials sits Mendelian randomization, which uses genetic variants assigned at conception as a kind of lifelong natural experiment, immune to most confounding. And at the very top sit systematic reviews and the consensus reports of independent expert bodies, which weigh everything below.

A claim that is only supported at the bottom of the pyramid and contradicted at the top is a weak claim. A claim supported at every single level is about as strong as nutrition science gets. Saturated fat’s role in heart disease, and the safety of replacing it with unsaturated plant oils, is the second kind of claim.

What saturated fat is, and why not all of it is the same

Before climbing the evidence, it helps to know exactly what is being argued about, because “saturated fat” is not a single substance. Most of the fat in food is triglyceride, a molecule made of three fatty acids attached to a glycerol backbone. The fatty acids are chains of carbon atoms, and they differ in two ways that decide almost everything that follows.

What makes a fat saturated?

The first difference is double bonds between the carbons in the chain. A saturated fatty acid has none. A monounsaturated fatty acid has one, and a polyunsaturated fatty acid has two or more. The fats this post defends, in olive oil and the seed oils, are the unsaturated ones. The fats it warns about are the ones with no double bonds at all.

Are all saturated fats the same?

No, and this is the part most arguments about saturated fat skip. The second difference is chain length, counted in carbon atoms. The saturated fats that matter most in food are lauric acid, with 12 carbons, myristic acid with 14, palmitic acid with 16, and stearic acid with 18. Palmitic and stearic acid are the most abundant in the diet, and some fats, including coconut oil and dairy fat, also contain fatty acids with fewer than 12 carbons.

They do not behave alike, and the analysis of controlled feeding trials commissioned by the World Health Organization estimated the effect of each one separately. Replacing 1 percent of daily calories from carbohydrate with myristic acid raised LDL cholesterol by 0.044 mmol/L; with palmitic acid, by 0.036; with lauric acid, by 0.017. Stearic acid showed no significant effect on LDL or on any other blood lipid measured. Among the four, myristic and palmitic acid are the strongest LDL-raisers and lauric acid is weaker.

Lauric acid, which coconut oil is loaded with, is the complicated case, because alongside its smaller LDL increase it also raises HDL cholesterol. Whether that makes coconut oil a reasonable choice is a separate argument, taken apart in full in Coconut Oil vs. Animal Fat.

Do the differences rescue animal fat?

They do not, because no food contains a single fatty acid. Stearic acid’s lack of a significant effect is a real finding, but in animal foods it does not arrive alone. It comes packaged with palmitic acid, one of the two most abundant saturated fats in the diet and one of the two strongest LDL-raisers. In meat, palmitic acid is the predominant saturated fatty acid, and dairy fat is about 27 percent palmitic acid, 12 percent stearic, 9 percent myristic, and 3 percent lauric. The fatty acid profiles of the two food kingdoms, and why the animal pattern is the one that raises LDL, are laid out in Animal Fat, Plant Fat, and the Journey From Your Plate to Your Arteries. The chemistry follows the molecules rather than the label, which is why “some saturated fats are neutral” is not a defense of butter or beef.

Is there a safe amount of saturated fat?

The official answer is that coronary risk rises with every increment, so the relationship behaves like a dial rather than a switch. The Dietary Reference Intakes, the nutrient standards for the United States and Canada, found a positive linear trend between saturated fat intake and both LDL cholesterol and coronary heart disease risk, and set no upper limit for exactly that reason: any incremental increase raises the risk. The genetic evidence described later in this post points the same way, with LDL tracking cardiovascular disease in a dose-dependent, log-linear fashion. More saturated fat, more LDL, more heart disease, step by step.

Is meat a protein food or a saturated fat food?

This deserves a reframe, because the usual one is backwards. Meat is usually thought of as the protein food, as though protein were what sets animal foods apart. It is not. Every essential amino acid is present in ordinary whole plant foods, from oats to broccoli to black beans, and the classic incomplete protein in the ordinary food supply is gelatin, which lacks tryptophan. Plants supply protein. What separates the two kingdoms is the package that comes with it. Essentially every whole animal food carries saturated fat, along with cholesterol and no fiber. Plant foods carry mostly unsaturated fat, with a few tropical exceptions, along with fiber, which animal foods lack entirely. If you want a single nutritional feature that separates animal foods from plant foods, protein is the wrong choice, since both supply it. The fat is the telling difference, together with the missing fiber. How plant protein stacks up, including the amino acids worth paying attention to, is covered in our post on protein.

Level 1: Mechanism, what happens inside the body

How does saturated fat raise LDL cholesterol?

Everything starts with low-density lipoprotein, the particle that carries cholesterol through the blood. The biology here is not controversial. Michael Brown and Joseph Goldstein won the 1985 Nobel Prize in Physiology or Medicine for working out the LDL receptor pathway: cells pull LDL particles out of circulation through receptors on their surface, and anything that reduces receptor activity leaves more LDL in the blood, where it can penetrate artery walls, become retained and modified, and trigger the inflammatory cascade that builds atherosclerotic plaque. A 2020 consensus statement from the European Atherosclerosis Society, authored by many of the world’s leading lipid scientists, lays out the modern picture of this pathway in exhaustive detail: LDL and related apoB-containing particles are not merely associated with atherosclerosis, they are the root cause of it.

The reason saturated fat raises LDL runs through those same receptors, and the liver is central to it. Saturated fat raises LDL both by increasing how much LDL is formed and by slowing how quickly it is cleared, while unsaturated fats increase the number of LDL receptors on the liver and speed clearance up. This has been measured in people: in a randomized crossover trial of 25 healthy adults, cutting saturated fat was associated with higher LDL receptor levels on their blood cells, a measure that reflects the liver’s own receptor status. Fewer receptors means LDL particles are cleared more slowly and circulate longer, and the longer a particle drifts, the more time it has to be chemically altered and oxidized into forms your immune system treats as a threat. That journey, from the liver to the artery wall, is traced step by step in Cholesterol, From the Ground Up and in our post on how plaque forms.

Do seed oils lower cholesterol in controlled feeding studies?

Where does diet plug in? Controlled feeding experiments answered this decades ago and have re-answered it ever since. When researchers control everything people eat and swap one fat for another, the results are so consistent they can be written as equations. Ancel Keys and colleagues derived one version in 1965, David Hegsted and colleagues independently derived nearly the same one the same year. Saturated fatty acids raise LDL cholesterol. Polyunsaturated fatty acids, the dominant fats in so-called seed oils, lower it. Ronald Mensink and Martijn Katan’s meta-analyses of dozens of tightly controlled feeding trials confirmed and refined these relationships, and Mensink’s 2016 systematic review and regression analysis, the World Health Organization-commissioned analysis cited above, covering 84 controlled trials, confirmed them again with modern methods: replacing saturated fat with polyunsaturated fat lowers LDL cholesterol, with that specific effect graded high certainty.

That analysis also ranked the replacements, and the ordering is worth holding onto, because it reappears later in this post at a completely different level of evidence. Swapping just 1 percent of daily calories out of saturated fat lowered LDL cholesterol by 0.055 mmol/L when the replacement was polyunsaturated fat, 0.042 when it was monounsaturated fat, and 0.033 when it was carbohydrate. Small numbers, because 1 percent of calories is a small change, but the rank order is the point: polyunsaturated fat moves LDL the most, monounsaturated fat next, carbohydrate least. Hold that sequence. When we reach the cohort studies tracking actual heart attacks over decades, the same three replacements line up in the same order.

So at the mechanistic level, the chain is complete and each link is independently verified: saturated fat raises LDL, LDL causes atherosclerosis, atherosclerosis causes heart attacks and strokes. Anyone claiming saturated fat is harmless has to break one of those links. As you will see, every attempt to do so fails at a higher level of evidence.

Level 2: Animal studies, a century of consistency

Can atherosclerosis be produced in the lab?

In 1913, Nikolai Anitschkow showed that feeding cholesterol to rabbits produced arterial lesions essentially identical to human atherosclerosis. In the century since, atherosclerosis has been produced in essentially every susceptible species tested, from primates to pigs to genetically modified mice, by raising blood levels of apoB-containing lipoproteins, and it regresses when those levels fall. Daniel Steinberg’s historical reviews of this literature document how thoroughly the animal evidence anticipated everything later confirmed in humans.

Animal studies alone prove nothing about dietary advice for people. But they establish something important for the hierarchy: the mechanism proposed at Level 1 actually produces disease in living arteries. The biology is not hypothetical.

Level 3: Ecological and migration studies, the weakest rung

What did the 1967 Indian railway worker study really show?

This is the tier where the famous comparisons live. Ancel Keys’ Seven Countries Study found that populations eating more saturated fat had more coronary disease. S. L. Malhotra’s 1967 comparison of Indian railway workers found the opposite pattern between North and South India, and the gap he reported was not subtle: heart disease deaths ran roughly seven times higher in the south overall, and about fifteen times higher among the railway sweepers doing comparable physical work. Carnivore influencers love the second study and hate the first one, which tells you everything, because they are the same kind of study with the same fatal weakness: whole populations differ in genetics, healthcare, diagnostics, smoking, activity, poverty, infection, and a hundred dietary variables at once.

Two-region comparisons cannot isolate any single cause, no matter how many individuals are counted. Be clear about what Malhotra actually found, because it is the whole basis of the seed-oil argument: the southern railway workers, who cooked in groundnut and sesame oil, had far more heart disease than the northern workers, who used ghee and ate several times more total fat. Taken at face value, that indicts the seed oils and exonerates the ghee. But an uncontrolled snapshot of two regions cannot separate cooking oil from genetics, diabetes, smoking, healthcare access, diagnostic practice, and refined-carbohydrate intake, all of which differed sharply between north and south, and South India remains a global hotspot of premature coronary disease today for reasons that have little to do with which oil is in the pan. That is exactly why a 1967 ecological survey does not get to outrank the controlled feeding studies, randomized trials, and genetic evidence stacked above it, all of which point the other way.

What did the Japanese migration studies find?

The strongest studies in this tier are migration studies, because they hold genetics constant. The Ni-Hon-San study followed Japanese men in Japan, Hawaii, and California. Same ancestry, radically different environments: coronary heart disease roughly doubled by the time the men reached California as diets westernized and saturated fat intake climbed, with the stepwise rise across all three sites clearest under the broader case definition, while stroke patterns moved in the opposite direction. Genes did not change on the boat. The environment did.

Ecological evidence generates hypotheses. It settles nothing. Everything from here up is what settles things.

Level 4: Prospective cohort studies

Why does it matter what you replace saturated fat with?

Cohort studies follow individual people, measure their diets repeatedly, and track outcomes for decades. Their great insight, and the source of nearly all the confusion the influencers exploit, is that you cannot just remove a nutrient from a diet. You replace it with something. The health effect of eating less saturated fat depends entirely on what fills the gap.

When the replacement question is handled properly, the cohort literature is remarkably consistent:

• A pooled analysis of 11 cohorts with 344,696 participants found that replacing 5 percent of energy from saturated fat with polyunsaturated fat was associated with about 13 percent fewer coronary events and about 26 percent fewer coronary deaths. Replacing it with carbohydrate, which in Western diets is largely refined starch and sugar, showed no benefit.
• A systematic review of 13 cohorts with 310,602 participants found that replacing saturated fat with linoleic acid, the main fatty acid in soybean, sunflower, corn, and safflower oil, was associated with roughly 9 percent lower coronary risk and 13 percent lower coronary mortality per 5 percent energy swap.
• In more than 120,000 participants of the Nurses’ Health Study and Health Professionals Follow-up Study, swapping 5 percent of calories from saturated fat for polyunsaturated fat was associated with about 25 percent lower coronary risk, for monounsaturated fat about 15 percent, and for whole-grain carbohydrate about 9 percent, while refined starches and sugars offered nothing. In the mortality analysis of the same cohorts, replacing saturated fat with polyunsaturated fat was associated with roughly 27 percent lower death rates over the follow-up period.
• In 2025, the largest and longest analysis of butter versus plant oils ever conducted followed 221,054 adults for up to 33 years, capturing 50,932 deaths. The highest butter consumers had 15 percent higher total mortality; the highest plant-oil consumers had 16 percent lower mortality; and modeled substitution of roughly a tablespoon of butter per day with plant oils, including soybean and canola, was associated with about 17 percent lower total and cancer mortality.

Now compare the Harvard cohort ranking with the one from the metabolic wards, three tiers of evidence back. In controlled feeding trials measuring nothing but blood lipids, the replacements ordered themselves polyunsaturated fat, then monounsaturated fat, then carbohydrate. In the Harvard cohorts counting actual heart attacks across decades, they order themselves polyunsaturated fat, then monounsaturated fat, then whole-grain carbohydrate, with refined carbohydrate at nothing. Two entirely different research methods, one measuring a molecule in a laboratory and the other counting heart attacks in the real world, producing the same sequence. That is what a real causal chain looks like when you check it from both ends.

What do blood tests say about linoleic acid and heart disease?

Diet questionnaires are imperfect, so researchers also went around them entirely and measured fatty acids directly in blood and tissue. Linoleic acid cannot be made by the human body, so your circulating level is an objective record of intake. A pooled analysis of 30 cohorts across 13 countries found that people with the highest linoleic acid biomarkers had lower risk of total cardiovascular disease, cardiovascular mortality, and ischemic stroke, with cardiovascular death running about 22 percent lower across the exposure range, and, critically, arachidonic acid levels were not associated with higher risk, undercutting the entire inflammation storyline. A parallel pooled analysis of 20 cohorts found higher linoleic acid biomarkers associated with substantially lower risk of type 2 diabetes. Systematic reviews of linoleic acid intake and biomarkers confirm lower all-cause, cardiovascular, and cancer mortality with higher levels, and a dose-response meta-analysis in Diabetes Care found the same protective pattern for diabetes.

What about the studies that found no link with saturated fat?

Now, the null studies the influencers cite. Siri-Tarino 2010 and Chowdhury 2014 found no significant association between saturated fat intake and heart disease. Neither is a smoking gun. Both compared high saturated fat eaters to low saturated fat eaters without accounting for what the low-fat eaters ate instead, and in Western cohorts the answer was mostly refined carbohydrate. Trading butter for white bread and soda is trading one problem for another, which is precisely what the replacement analyses above demonstrate, and it is exactly the interpretation the authors of major reviews have given. The PURE study is cited the same way: across 18 countries it found higher total fat intake associated with lower mortality, but its low-fat, high-carbohydrate comparison groups were dominated by low-income populations eating enormous amounts of white rice and refined grains, and even PURE found no signal of harm from polyunsaturated fat. None of these studies show saturated fat is protective, and none show plant oils are harmful. They show that refined carbohydrate is a terrible replacement, which every mainstream body already says.

Level 5: Randomized controlled trials

Have seed oils actually been tested in randomized trials?

This is the level the entire debate should live on, and it is the level the influencer narrative most needs you to ignore.

The classic trials randomized people to replace saturated fats with polyunsaturated vegetable oils and tracked hard outcomes for years. The Los Angeles Veterans trial, 846 men, eight years, double-blind institutional feeding: fewer atherosclerotic events in the vegetable-oil group. The Oslo Diet-Heart Study: fewer coronary events and, at eleven years, lower coronary mortality in the intervention group. The Finnish Mental Hospital Study, a twelve-year crossover in two hospitals: roughly halved coronary mortality on the polyunsaturated-oil diet. The British Medical Research Council’s soybean oil trial pointed the same direction without reaching significance on its own.

What about the Sydney Diet Heart Study and Minnesota Coronary Experiment?

Then there are the two rehabilitated trials that the entire modern anti-seed-oil movement is built on: the Sydney Diet Heart Study and the Minnesota Coronary Experiment, whose recovered data were reanalyzed in 2013 and 2016. Two things are true about them. First, they deserve to be in the record, and they are. Second, they cannot carry the weight placed on them. Sydney’s intervention delivered its polyunsaturated fat as liquid safflower oil and a safflower margarine that, like margarines of that era, very likely contained industrially produced trans fats, the one fat every scientist on every side agrees is atherogenic, confounding the very comparison the trial was meant to make. Minnesota’s problem is different and, if anything, simpler: its participants were institutionalized patients in a hospital system with heavy turnover, and mean follow-up came to just 2.9 years, which is far too brief a window to test an intervention against a disease that develops over decades. Building a movement on these two trials while ignoring the rest is not skepticism. It is curation.

What happens when you pool all the trials together?

Which is why the honest move is to pool all the trials, including the unfavorable ones, and see what the totality shows. That has been done repeatedly:

• Mozaffarian, Micha, and Wallace pooled the randomized trials in 2010: replacing saturated fat with polyunsaturated fat reduced coronary events by about 19 percent overall, roughly 10 percent for every 5 percent of energy exchanged, with longer trials showing larger benefits.
• The Cochrane Collaboration, the most methodologically conservative review body in medicine, published its most recent systematic review in 2020: 15 randomized trials with 56,675 participants and, in the 12 long-term trials that measured it, a 17 percent reduction in combined cardiovascular events from reducing saturated fat, with a dose-response relationship in which trials achieving bigger cholesterol reductions achieved bigger event reductions, exactly what the mechanism at Level 1 predicts. Cochrane includes the Sydney and Minnesota data. The result stands anyway.
• The one meta-analysis that reaches a null conclusion, Hamley 2017, does so by excluding most of the trials as inadequately controlled and analyzing the small remainder, which lacks the statistical power to detect anything. It is a legitimate methodological argument worth reading, and it is also the outlier against Cochrane, against Mozaffarian, and against the dose-response gradient that Hamley’s approach cannot explain.

What should you replace saturated fat with?

The American Heart Association’s 2017 Presidential Advisory, an exhaustive review led by Frank Sacks of Harvard, concluded that in the core randomized trials, replacing saturated fat with polyunsaturated vegetable oil cut cardiovascular disease by roughly 30 percent, a reduction in the same range as statin therapy. That is the trial-level version of the lesson the cohorts taught above: refined carbohydrate and sugar are no better than the saturated fat they replace, and unsaturated plant fats are. The lesson is not that fat is fine or that fat is deadly. It is that what you put in the empty space decides the outcome.

Didn’t the Women’s Health Initiative disprove the low-fat diet?

Two trials the skeptics wave around deserve their own sentences. The Women’s Health Initiative dietary trial was null for heart disease, and it was designed to test a low total fat diet, not saturated fat replacement. The intervention barely moved the thing that matters: LDL cholesterol fell by just 3.55 mg/dL against the comparison group. A trial that does not lower the causal particle is not a test of whether lowering the causal particle helps, so it answered a question nobody is defending. And PREDIMED, one of the largest dietary prevention trials ever run, randomized high-risk adults to a Mediterranean diet supplemented with extra-virgin olive oil or nuts and found roughly 30 percent fewer major cardiovascular events than a nominally lower-fat control diet, a result that survived a full reanalysis and republication after protocol irregularities at a minority of sites were corrected. Unsaturated plant fat, in a trial, at scale, reduced heart attacks and strokes.

And on the specific fear of omega-6 oils: Cochrane’s dedicated review of omega-6 fats in randomized trials found no evidence of harm on any outcome, with a possible reduction in heart attacks.

Sixty years of randomized trials. Not one adequately controlled trial shows that replacing saturated fat with unsaturated plant oils causes harm; the only mortality signals against the swap come from the two outliers above, one confounded by the margarine of its era and the other far too short, which is why pooling the evidence properly matters. In fairness, the strictest reading of “adequately controlled,” the one Hamley applies, also shrinks the measured benefit, because it discards most of the trial evidence in both directions. What it never produces is evidence of harm. That is the single most important paragraph in this post.

Level 6: Genetics, Mendelian randomization, and drug trials

How do we know LDL causes heart disease and is not just a marker?

If the whole diet-heart framework were wrong, this is the level where it would collapse, because these methods are immune to the confounding that plagues nutrition studies. Instead, this is where it is confirmed most decisively.

People born with familial hypercholesterolemia carry genetic variants that raise LDL from birth, and untreated, they develop coronary disease decades early, with severity tracking their LDL burden; people born with variants that lower LDL show the mirror image. Mendelian randomization studies, which use randomly inherited gene variants as lifelong natural experiments, show that every independent genetic mechanism that lowers LDL lowers coronary risk in proportion to the LDL change and its duration, and long-term genetic exposure produces roughly three times the benefit per unit of LDL that a few years of drug treatment does. The European Atherosclerosis Society’s consensus panel reviewed over 200 studies covering more than 2 million participants and 20 million person-years and concluded that LDL causes cardiovascular disease in a dose-dependent, cumulative way, with no threshold below which lowering it stops helping.

Do cholesterol-lowering drugs prove the point?

The drug trials seal it, and they matter for the diet debate more than people realize. Statin meta-analyses covering 170,000 randomized participants show cardiovascular events fall by about a fifth for every 1 mmol/L of LDL reduction. Skeptics used to answer that statins work through some special anti-inflammatory magic unrelated to LDL. Then ezetimibe, a completely different drug class, lowered LDL by a different mechanism and reduced events in proportion. Then PCSK9 inhibitors, a third mechanism, lowered LDL dramatically and reduced events again. And in 2023, bempedoic acid, a fourth mechanism that throttles cholesterol synthesis two enzymatic steps upstream of where statins act, at ATP-citrate lyase rather than HMG-CoA reductase, cut cardiovascular events in nearly 14,000 statin-intolerant patients in the CLEAR Outcomes trial. Four unrelated drug mechanisms, one common factor, one consistent result. Diet reaches the same particle by a fifth route, with no prescription required: pooling 30 randomized trials, moving people from an omnivorous diet to a vegetarian or vegan one lowered LDL cholesterol by about 12 points and apolipoprotein B, the particle count that predicts risk most directly, by roughly 13 mg/dL. It is the LDL. And saturated fat raises LDL while polyunsaturated fat lowers it, which is the whole point.

This is what researchers call triangulation: mechanism, feeding trials, cohorts, outcome trials, genetics, and pharmacology all converging on the same answer through methods with completely different weaknesses. Conspiracies do not survive triangulation. If you want the full molecular story of how an LDL particle actually builds a plaque, from the ApoB protein to the cholesterol crystals, that is the subject of Cholesterol, From the Ground Up and of our post on how plaque forms.

The second disease: saturated fat and type 2 diabetes

Everything so far has been about the heart, but saturated fat is a cardiometabolic problem, and the same fat that raises LDL also sits at the center of type 2 diabetes. That link is worth spelling out, because it corrects one of the most common confusions in popular nutrition: the belief that carbohydrate causes diabetes. The underlying defect in type 2 diabetes is insulin resistance, and one of its best-documented drivers is fat accumulating where it does not belong, inside muscle and liver cells. The fuller case on carbohydrates is made in our post on carbs; here is the part that concerns fat.

Does saturated fat cause insulin resistance?

The mechanism has been traced molecule by molecule, and a 2016 review pulled that research together. When fat builds up inside muscle cells, it is not stored inertly. Some of it is converted into signaling molecules, chiefly diacylglycerol and ceramide, which activate an enzyme family called protein kinase C and interfere with IRS-1, a relay in the chain that carries insulin’s signal. The signal stalls, and the muscle takes up less glucose from the blood. The review cites a human study in which infusing fat into the bloodstream raised muscle diacylglycerol about threefold alongside exactly those enzyme changes, and cell experiments in which pure palmitic acid, the major saturated fat in the diet, raised diacylglycerol and impaired insulin signaling more than mixed fatty acids did. Much of this finest-grained work is in cells and animals, and the review itself cautions that the mechanisms operating in rodents may differ from those in humans, so the molecule-level detail is best held as strong mechanistic evidence rather than a finished account of human physiology.

Can a high-fat diet worsen blood sugar in just a few days?

It can, and the effect shows up fast. In a crossover study, nine healthy young men ate a normal diet with about 22 percent of calories from fat for three days, and a low-carbohydrate, high-fat diet with about 69 percent of calories from fat for three days, with total calories similar. After each, they drank a standard glucose load. After the high-fat diet, their blood glucose during that test was significantly higher, and the first rapid burst of insulin secretion was significantly weaker. Some of that short-term response likely reflects the body adapting to less carbohydrate, so it is not by itself proof of disease, and nine men over three days is a small window. But the direction is the opposite of what the low-carb framing predicts: loading up on fat made the handling of sugar worse, not better.

Is saturated fat worse than seed oil for liver and belly fat?

This is where the two kinds of fat were put head to head, and the seed oil is the one that came out ahead. In a double-blind randomized trial, 39 young, normal-weight adults were overfed muffins for seven weeks, made with either palm oil, rich in saturated palmitic acid, or sunflower oil, rich in the polyunsaturated linoleic acid that seed-oil critics object to. Both groups gained similar weight. But the saturated fat markedly increased liver fat and produced about twice the increase in visceral fat, the fat packed around the abdominal organs, while the sunflower oil produced nearly three times the gain in lean tissue. Same calories, same weight on the scale, and the saturated fat sent the extra energy into exactly the depots most tied to insulin resistance and type 2 diabetes.

One honest limit: the researchers state that the trial was not designed or powered to measure insulin sensitivity, and they did not measure it directly. So this trial shows saturated fat filling the liver and visceral depots, not a measured change in insulin resistance itself. Taken with the mechanism above and with the biomarker studies described earlier, in which people with the most linoleic acid in their blood had substantially lower rates of type 2 diabetes, the picture is consistent across very different kinds of evidence.

So why does carbohydrate get the blame?

Because it is where the problem becomes visible. A person whose muscles and liver have stopped responding properly to insulin cannot clear a load of glucose efficiently, so eating carbohydrate raises their blood sugar, and the carbohydrate looks like the culprit. But the defect was already there. That does not make refined carbohydrate and sugar harmless, and the replacement evidence earlier in this post shows they are a poor substitute for saturated fat. It does mean that cutting carbohydrate treats the reading on the meter rather than the resistance underneath it, and that the fat accumulating in muscle and liver, with saturated fat the worst offender, deserves far more of the attention than it gets.

The confusion also has deep roots. Until the 1930s, every case of diabetes was assumed to be a shortage of insulin. The physician Harold Himsworth separated diabetes into insulin-sensitive and insulin-insensitive types in 1936, and his earlier experiments showed that a diet rich in fat worsened tolerance to sugar and blunted the action of insulin on blood sugar, while diets richer in carbohydrate improved it. He demonstrated it first in healthy men and then confirmed it in animal experiments. Today, most people with type 2 diabetes already have insulin resistance at diagnosis: the pancreas is still producing insulin, but the body cannot use it effectively. The full cause is still not settled, and liver, fat, and muscle cells are all thought to play a role, along with the insulin-producing cells of the pancreas.

Level 7: The verdict of every major scientific body on Earth

Does any health organization recommend eating more saturated fat?

Independent expert panels exist to weigh everything above. Here is where they have landed. Not one major scientific organization in the world recommends increasing saturated fat or avoiding unsaturated plant oils. Not one.

• World Health Organization (2023). After commissioning its own systematic reviews, WHO issued a strong recommendation to reduce saturated fat, a conditional recommendation to keep it below 10 percent of energy, and a strong recommendation to replace it preferably with polyunsaturated fats from plant sources, along with plant-source monounsaturated fats or fiber-rich carbohydrates. The evidence that saturated fat raises LDL cholesterol was graded high certainty, and the evidence that polyunsaturated replacement lowers cardiovascular disease and death was graded moderate certainty, which is why WHO made that replacement recommendation strong even on moderate-certainty evidence.
• Institute of Medicine of the National Academies. The Dietary Reference Intakes, the foundational nutrient standards for the US and Canada, found that saturated fat is made by the body and has no known beneficial role in preventing chronic disease, so it is not required in the diet. It set no upper limit, because any incremental increase in saturated fat intake increases coronary heart disease risk, and it recommended keeping intake as low as possible while eating a nutritionally adequate diet.
• The 2025 Dietary Guidelines Advisory Committee, the panel of twenty independent scientists whose report underpins US policy, reviewed the newest evidence and specifically concluded that substituting butter with plant-based oils and spreads is associated with lower cardiovascular disease risk and mortality.
• The Dietary Guidelines for Americans 2025 to 2030, released in January 2026 by an administration that had spent months publicly attacking seed oils and promoting beef tallow, still could not overturn the science: the final document retains the limit of 10 percent of calories from saturated fat and tells Americans to prioritize oils rich in essential fatty acids when cooking. When even the most saturated-fat-friendly government in modern American history reviews the evidence and keeps the cap, the evidence is not ambiguous.
• American College of Cardiology and American Heart Association joint prevention guidelines recommend diets that minimize saturated fat in favor of unsaturated fats, vegetables, fruits, legumes, whole grains, and nuts, and the AHA’s 2021 dietary guidance and 2017 Presidential Advisory say the same with the full evidence review attached.
• American Diabetes Association consensus guidance advises replacing saturated fat with unsaturated fats and endorses Mediterranean-style eating patterns for cardiovascular risk.
• American Cancer Society guidelines call for eating patterns centered on vegetables, fruits, whole grains, and legumes while limiting red and processed meat.
• American Academy of Pediatrics, through the NHLBI expert panel guidelines it endorses, recommends limiting saturated fat to under 10 percent of calories for every child from age two onward.
• Academy of Nutrition and Dietetics, the largest organization of nutrition professionals in the world, concluded in its 2023 evidence-based practice guideline that reducing saturated fat and replacing it with polyunsaturated fat benefits cardiovascular health, and holds as its current position that appropriately planned vegetarian and vegan dietary patterns are nutritionally adequate for adults and can improve cardiometabolic outcomes. Its most recent all-life-stages position, from 2016, judged well-planned vegan diets appropriate for every stage of life including pregnancy, infancy, childhood, and athletics.
• American College of Lifestyle Medicine recommends eating patterns built predominantly on minimally processed vegetables, fruits, whole grains, legumes, nuts, and seeds for chronic disease treatment and prevention.
• European Society of Cardiology prevention guidelines: saturated fat under 10 percent of energy, replaced with polyunsaturated and monounsaturated fats and whole-grain carbohydrates.
• United Kingdom’s Scientific Advisory Committee on Nutrition conducted a multi-year review published in 2019 and reaffirmed the 10 percent limit with replacement by unsaturated fats.
• Nordic Nutrition Recommendations (2023), among the most rigorous national processes anywhere, reached the same conclusion for Denmark, Finland, Iceland, Norway, and Sweden, alongside a broader shift toward plant-predominant eating.
• National Heart Foundation of Australia recommends replacing butter and other saturated fat sources with plant oils, nuts, seeds, and avocado. Health Canada’s national dietary guidelines say the same. The World Cancer Research Fund and American Institute for Cancer Research global report points the same direction for cancer prevention.

That is the United States, the United Nations’ health agency, Europe’s leading cardiology society, the UK, all five Nordic countries, Australia, and Canada, spanning cardiology, diabetes, cancer, pediatrics, and dietetics. For the influencer narrative to be true, every one of these independent bodies, across rival nations and competing specialties, reviewing the evidence in different decades with different methods, would have to be wrong in the same direction at the same time, and a handful of podcasters would have to be right. That is not how any of this works.

The seed oil claims, tested directly

Do seed oils cause inflammation?

The case against seed oils rests on a mechanistic story: omega-6 linoleic acid converts to arachidonic acid, arachidonic acid feeds inflammatory pathways, therefore seed oils cause chronic inflammation and disease. Every step of this story has been tested in humans, and every step fails.

A systematic review of randomized trials found that even large increases in dietary linoleic acid do not raise inflammatory markers such as C-reactive protein, interleukin-6, or TNF-alpha. A separate systematic review found that increasing dietary linoleic acid does not meaningfully raise arachidonic acid in blood or tissue, because the conversion enzyme is tightly regulated. The name of that enzyme is worth knowing, because it explains why the storyline fails on contact with biochemistry: converting linoleic acid to arachidonic acid runs through delta-6-desaturase, encoded by the gene FADS2, the same rate-limiting bottleneck the body uses to control its own supply of these signaling fats regardless of how much raw material arrives from the diet. Flooding the system with linoleic acid does not flood the arachidonic acid pool, because the bottleneck does not widen. There is a further problem with the story, which is that the pathway does not lead only to inflammatory products. Linoleic acid is converted along the way to dihomo-gamma-linolenic acid, or DGLA, which gives rise to anti-inflammatory mediators of its own. The clean picture where omega-3 is the anti-inflammatory family and omega-6 is the inflammatory one does not survive contact with the actual biochemistry. The American Heart Association’s science advisory on omega-6 fats reviewed this literature and concluded that intakes of at least 5 to 10 percent of energy from omega-6 polyunsaturated fat are safe and beneficial. The biomarker consortium described earlier found that people with the highest measured arachidonic acid did not have higher cardiovascular risk. The broader question of how diet affects inflammation is covered in our post on the anti-inflammatory diet.

Meanwhile, the foods that actually supply preformed arachidonic acid are doing something the seed-oil story never mentions. Meat, poultry, and eggs deliver arachidonic acid ready-made, bypassing the desaturase bottleneck entirely, and animal protein that escapes digestion in the small intestine reaches the colon, where resident bacteria putrefy it into hydrogen sulfide, ammonia, phenols, and indoles. In a controlled crossover trial, a high-meat diet produced roughly three times the presumptive carcinogenic N-nitroso compounds of a low-meat diet, 114 versus 35 micrograms a day, and twice the fecal ammonia, 2.9 versus 1.4 millimoles a day. Adding fiber-rich resistant starch on top of the high-meat diet did not rescue the numbers. It was a small study, eight healthy men in a three-period crossover, but the chemistry it describes happens in the bowel itself, regardless of how the meat was raised or cured. Seed oils carry no protein to putrefy. The inflammatory and carcinogenic load this story is looking for sits in the food supplying the arachidonic acid directly, not in the one supplying an essential fat the body carefully regulates.

What does the newest research on omega-6 say?

The newest data keeps landing the same way. A 2026 analysis of nearly 1,900 adults found that higher measured blood levels of linoleic acid were associated with lower C-reactive protein and lower glycoprotein acetyls, both inflammation markers, along with better glucose and insulin measures, the exact opposite of the inflammation claim. A 2026 evidence review in Nutrition Today concluded that clinical trial evidence shows linoleic acid does not promote inflammation or oxidative stress, and a 2026 clinician’s guide in JACC: Advances, written for cardiologists fielding these exact questions from patients, summarized the trial and biomarker literature the same way: no proinflammatory effect, favorable effects on LDL, triglycerides, glucose, and insulin sensitivity, and lower observed rates of heart disease, stroke, diabetes, and death with higher omega-6 intake. One disclosure worth making, because critics will raise it: some authors of the newest omega-6 papers have research or advisory ties to the food and edible-oil industry. That is a reason to read them carefully, not a reason to dismiss them, and it is also why the weight of the case here rests on the independent work: the 30-cohort biomarker consortium, the Cochrane reviews, and the randomized trials, none of which depend on industry funding.

Is beef tallow a healthier alternative to seed oils?

That same guide sorted the popular alternatives into three groups, and the middle one is the tell: alongside “evidence of harm, limit or avoid,” where beef tallow landed because it raises LDL cholesterol, and “evidence of benefit,” where seed oils and seafood landed, sat a neutral tier for items the evidence simply does not condemn or endorse, including full-fat dairy, MCT oil, and the nonsugar sweeteners monk fruit and stevia. This is not a document that reflexively condemns animal fat or blesses anything from a plant. It sorted by evidence, and seed oils came out on the favorable side while tallow did not.

Didn’t chronic disease rise along with seed oil consumption?

It did, and the timeline is the problem with that argument rather than the support for it. American obesity rates began their steep climb in the 1970s. The fast food industry’s switch away from beef tallow came around 1990, when McDonald’s and others moved their fryers to vegetable oil under pressure from campaigners who considered saturated animal fat the greater evil. A cause cannot arrive two decades after the effect it supposedly produced. Whatever was driving the curve upward through the 1970s and 1980s was already driving it before the oils arrived.

As for the broader correlation, the rise of seed oils parallels the rise of chronic disease, and so does the rise of television, air conditioning, and plastic packaging. Correlation across a century of total dietary and lifestyle transformation is Level 3 evidence at its weakest, offered by people who reject Level 3 evidence whenever it points the other way.

Reading the evidence precisely

What do the seed oil skeptics get right?

Strong science means stating exactly what is known, no more and no less, so here is the precision that a fair reader should hold onto.

The evidence indicts refined carbohydrate as a replacement for saturated fat just as clearly as it endorses unsaturated fat; nobody credible is defending white bread. The evidence is about replacement and pattern, not fat as a poison in any dose; the benefit comes from what displaces what. Food sources matter: fermented dairy foods show weaker associations with harm than butter does, which is a statement about food matrices, not a rehabilitation of saturated fat, and the same butter that sits inside “neutral” total-dairy analyses shows clear harm when studied on its own.

The same molecules-not-slogans point holds even when the label on the diet has nothing to do with saturated fat at all. In the single most tightly controlled comparison available, twenty adults lived on an NIH metabolic ward and ate two diets in random order, two weeks each, with unlimited food: a minimally processed plant-based low-fat diet and a minimally processed animal-based ketogenic diet. Left to eat as much as they wanted, people spontaneously ate 689 fewer calories a day on the plant-based diet, with no difference in hunger or enjoyment, and only the plant-based diet produced a significant loss of body fat, while fat-free mass fell on the ketogenic diet instead. Low-fat and low-carb are both slogans. Whole-food plant matrix and animal-based matrix are the molecules underneath them, and the Cochrane trial evidence and this metabolic-ward trial are measuring the same distinction from two different angles.

Aren’t seed oils just a marker for junk food?

This is the strongest honest argument the skeptics have, and it deserves a direct answer rather than a dismissal. Seed oil intake tracks almost perfectly with ultra-processed food intake. The people eating the most soybean and corn oil are, overwhelmingly, the people eating the most fried food, packaged snacks, and fast food. Ultra-processed foods supply more than half of all calories in the American diet and nearly 90 percent of added sugar calories, and a large umbrella review of meta-analyses has tied them to a wide range of adverse health outcomes. So when a study finds that high seed oil consumers have worse health, the obvious question is whether the oil did anything at all, or whether it was simply riding along in the fryer.

Two things answer this. The first is that the confounding, if it were the whole story, would push the results in the wrong direction for the skeptics’ case. If seed oil intake is a proxy for junk food, then studies of seed oil intake should show harm. They do not. The cohorts find lower cardiovascular risk, lower diabetes risk, and lower mortality with higher intake, which is the opposite of what a junk food proxy would produce.

The second, and more decisive, is that researchers stopped asking people what they ate. The biomarker studies described earlier measured linoleic acid directly in blood and tissue, which sidesteps the entire problem: a molecule in your bloodstream does not know whether it arrived in a doughnut or in a salad dressing. Across 30 cohorts in 13 countries, the people with the most linoleic acid in their blood had less cardiovascular disease and lower cardiovascular mortality, and a parallel analysis of 20 cohorts found less type 2 diabetes. The randomized trials do the same thing by a different route, assigning the oil deliberately rather than observing who happened to eat it.

None of this is an argument for ultra-processed food. It is genuinely worth reducing, for reasons that have nothing to do with which oil is in it, and the case against it is far better established than anything ever demonstrated against linoleic acid. But that is a case about the food, not the fat. Swapping the frying medium in an ultra-processed product does not redeem it, and swapping it for beef tallow makes the one measure we can predict with confidence, LDL cholesterol, worse rather than better. The fried food is the problem. The oil is the passenger being blamed for the crash.

What has not been answered yet?

Here is the honest boundary of everything above, and it matters because the question most whole-food plant-based eaters are actually asking is not the question these studies answered.

Nearly all of this evidence compares plant oils against animal fats, or against refined carbohydrate. On that comparison the verdict is settled and not close. What remains genuinely open is a different question: among people already eating a whole-food plant-based diet, does adding extracted oil help, hurt, or do nothing compared with getting the same fats from whole olives, nuts, seeds, and avocados? That is the Esselstyn and Ornish position, and no study cited in this post settles it, because none were built to.

The closest thing we have is a 2024 randomized crossover trial. Forty adults at elevated cardiovascular risk followed a whole-food plant-based vegan diet twice, once with four tablespoons of extra virgin olive oil a day and once with under a teaspoon, four weeks each. Both versions significantly lowered LDL cholesterol, ApoB, glucose, and C-reactive protein. The low-oil arm trended toward lower LDL, but the difference did not reach statistical significance overall, and the result was complicated by a strong order effect: people who went from high oil down to low oil dropped their LDL by about 13 mg/dL, while people who went from low oil up to high oil saw it rise by about 16 mg/dL. That is suggestive, not conclusive.

Note what that trial was not. Four weeks is not a hard endpoint. Forty people is small. The participants were at elevated cardiovascular risk, not metabolically healthy. And nobody has run the study that would actually settle it: metabolically healthy people following every pillar of lifestyle medicine, eating whole plant foods, randomized to oil or no oil, followed for years, with heart attacks and deaths as the outcome. That study does not exist. It may never exist, because it would be expensive and nearly impossible to blind.

There is also a real-world consideration the trials rarely capture. A lean, highly active person on a whole-food plant-based diet can struggle to eat enough calories, since whole plant foods are bulky and filling. For that person, a drizzle of olive oil is a practical tool rather than a metabolic burden, and the saturated fat question is close to moot because they are burning what they eat. Someone sedentary and eating past their energy needs is in a different situation entirely. The same tablespoon does not mean the same thing to both people.

So the precise claim this post defends is narrower than it might appear, and it is worth stating plainly: seed oils are not poison, they do not drive inflammation, and replacing animal fat with them lowers cardiovascular risk. Whether a spoonful of any extracted oil belongs in an already excellent whole-food plant-based diet is a separate question, one where reasonable people who read the same evidence still disagree, and where the honest answer is that we do not yet know.

Is coconut oil an exception?

Coconut oil, the favorite loophole, has been tested in controlled trials: it raises LDL cholesterol significantly compared with other plant oils, exactly as its fatty acid profile predicts, a case worked through rung by rung, including the lauric-acid-and-HDL wrinkle that coconut defenders lean on, in Coconut Oil vs. Animal Fat.

Is olive oil healthier than seed oils?

This is the concession the skeptics reach for once the anti-seed-oil case collapses: fine, plant oil is acceptable, but only olive oil, the ancient one, not the industrial seed oils. It is worth answering directly, because the mechanism actually runs the other way from the slogan.

Start with what unites them. Every unsaturated plant oil does the reverse of what butter and tallow do at the liver. Where the saturated fat in butter and tallow turns down the LDL receptors that clear cholesterol from your blood, both the monounsaturated fat in olive oil and the polyunsaturated fat in seed oils increase the number of those receptors and speed clearance up. Olive oil’s signature fat is oleic acid, the monounsaturated fat of olives, avocados, and most nuts, and it also carries polyphenols like hydroxytyrosol, for which European regulators approved a formal health claim that they help protect blood lipids from oxidation. Olive oil is genuinely good, and nothing here argues against it.

But on the single measure this whole post is about, lowering the LDL particles that drive heart disease, polyunsaturated fat beats monounsaturated fat. The controlled feeding data show it directly, with polyunsaturated fat lowering LDL more per unit of saturated fat replaced, and the cohort data show the same order in coronary risk: about 25 percent lower for polyunsaturated fat versus about 15 percent for monounsaturated. The demonized seed oils are, on LDL lowering, slightly more effective than the celebrated olive oil, not less. The honest ranking is that both are excellent and both sit in a different universe from butter and tallow, which is the only comparison that matters at the dinner table. The receptor mechanism behind this, and olive oil’s polyphenol story in full, is walked through in Animal Fat, Plant Fat, and the Journey From Your Plate to Your Arteries.

Do seed oils only matter for the heart?

No. The diabetes evidence above is one reason. Vitamin E is another: seeds and nuts, the foods these oils are pressed from, are among the richest sources of it in the food supply, and it is a fat-soluble antioxidant that travels inside the same lipoprotein particles this post has been discussing. There is a genuine case that it helps protect those particles from the oxidation that makes them dangerous, though isolated vitamin E supplements have not reproduced that benefit in trials. One connection worth flagging and correcting rather than repeating: it is tempting to extend this into a story where fat-soluble vitamin K, riding the same route, protects bone the way vitamin E protects arteries. The trial evidence does not support that leap. The two largest randomized trials of vitamin K2 for slowing arterial or bone calcification, run in Denmark and the Netherlands, both failed their primary endpoint, and the K2-for-bone literature is thin and mixed. The genuinely strong, well-supported bone-protective signal in a plant-forward diet runs through a completely different nutrient, the amino acid lysine concentrated in legumes, which is covered properly, with its own randomized and cohort evidence, in Animal Fat, Plant Fat, and the Journey From Your Plate to Your Arteries.

None of these refinements move the conclusion a millimeter. They are the difference between science and slogans.

The bottom line

Walk the pyramid one more time. The mechanism is Nobel Prize biology. The feeding trials are so consistent they became equations. The animal models reproduce the disease on demand. The migration studies show genes are not destiny. The cohorts, hundreds of thousands of people over decades, show lower disease and death when unsaturated plant fats replace saturated fats, whether diet is measured by questionnaire or by molecules in blood. The randomized trials, pooled honestly with every unfavorable result included, show cardiovascular events fall when the swap is made, in proportion to how much LDL falls. The genetics show LDL is causal beyond any statistical doubt. Four separate classes of drugs confirm it. And the same saturated fat that raises LDL fills the liver and visceral fat depots most tied to insulin resistance, which makes this a cardiometabolic story, not only a cardiac one. And every major scientific body in the world, across every relevant specialty and a dozen countries, including a US administration openly hostile to the conclusion, has reviewed this record and landed in the same place: limit saturated fat, and replace it with unsaturated fats from plants.

Against all of that stands a 1967 two-region survey, two trials compromised, one by the margarine of its era and the other by brief follow-up, a couple of meta-analyses that forgot to ask what people ate instead, and a mechanistic story about inflammation that fails every time it is tested in actual humans.

How do you evaluate a viral nutrition study?

So the next time a post tells you one forgotten study overturns the science, ask three questions. What level of the hierarchy is this study from? What do the levels above it say? And what did every independent expert body conclude after reading all of it? The answers end the argument every time.

For readers who want to go deeper, NutritionFacts.org maintains a free, ad-free video library reviewing the primary literature on these topics, and the full reports of the organizations cited below are publicly available.

Keep reading

This post is part of a series that walks the same evidence pyramid through different corners of the dietary fat debate. If seed oils were your entry point, these go deeper on the pieces this post could only summarize:

• Cholesterol, From the Ground Up traces a single LDL particle from your dinner plate into the artery wall and explains exactly how a plaque is built, which is the mechanism this post takes as its starting point.
• Animal Fat, Plant Fat, and the Journey From Your Plate to Your Arteries covers the digestion physiology and the animal-versus-plant fatty acid contrast, and takes apart the fad-diet “I feel great” illusion.
• Coconut Oil vs. Animal Fat settles the one saturated fat that keeps getting a health halo, and shows why “it raises HDL” does not rescue it.
• Our post on how plaque forms follows what happens inside the artery wall once LDL particles get there.
• Our post on carbs takes on the idea that carbohydrate is what causes type 2 diabetes.
• Our post on protein covers plant protein quality and the complete protein myth.
• Our post on the anti-inflammatory diet looks at how dietary patterns affect inflammation.

References

1. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34–47.
2. Borén J, Chapman MJ, Krauss RM, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2020;41:2313–2330.
3. Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet. Metabolism. 1965;14:747–787.
4. Hegsted DM, McGandy RB, Myers ML, Stare FJ. Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr. 1965;17:281–295.
5. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials. Arterioscler Thromb. 1992;12:911–919.
6. Mensink RP. Effects of Saturated Fatty Acids on Serum Lipids and Lipoproteins: A Systematic Review and Regression Analysis. Geneva: World Health Organization; 2016.
7. Anitschkow N, Chalatow S. On experimental cholesterin steatosis and its significance in the origin of some pathological processes (1913). English reprint: Arteriosclerosis. 1983;3:178–182.
8. Steinberg D. An interpretive history of the cholesterol controversy, part I. J Lipid Res. 2004;45:1583–1593.
9. Keys A, ed. Coronary heart disease in seven countries. Circulation. 1970;41(suppl 1):1–211.
10. Malhotra SL. Epidemiology of ischaemic heart disease in India with special reference to causation. Br Heart J. 1967;29:895–905.
11. Malhotra SL. Geographical aspects of acute myocardial infarction in India with special reference to patterns of diet and eating. Br Heart J. 1967;29(3):337–344.
12. Kato H, Tillotson J, Nichaman MZ, Rhoads GG, Hamilton HB. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: serum lipids and diet. Am J Epidemiol. 1973;97:372–385.
13. Marmot MG, Syme SL. Acculturation and coronary heart disease in Japanese-Americans. Am J Epidemiol. 1976;104:225–247.
14. Jakobsen MU, O’Reilly EJ, Heitmann BL, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009;89:1425–1432.
15. Farvid MS, Ding M, Pan A, et al. Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation. 2014;130:1568–1578.
16. Li Y, Hruby A, Bernstein AM, et al. Saturated fats compared with unsaturated fats and sources of carbohydrates in relation to risk of coronary heart disease. J Am Coll Cardiol. 2015;66:1538–1548.
17. Wang DD, Li Y, Chiuve SE, et al. Association of specific dietary fats with total and cause-specific mortality. JAMA Intern Med. 2016;176:1134–1145.
18. Zhang Y, Chadaideh KS, Li Y, et al. Butter and plant-based oils intake and mortality. JAMA Intern Med. 2025;185:549–560.
19. Marklund M, Wu JHY, Imamura F, et al. Biomarkers of dietary omega-6 fatty acids and incident cardiovascular disease and mortality: an individual-level pooled analysis of 30 cohort studies. Circulation. 2019;139:2422–2436.
20. Wu JHY, Marklund M, Imamura F, et al. Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39,740 adults from 20 prospective cohort studies. Lancet Diabetes Endocrinol. 2017;5:965–974.
21. Li J, Guasch-Ferré M, Li Y, Hu FB. Dietary intake and biomarkers of linoleic acid and mortality: systematic review and meta-analysis of prospective cohort studies. Am J Clin Nutr. 2020;112:150–167.
22. Mousavi SM, Jalilpiran Y, Karimi E, et al. Dietary intake of linoleic acid, its concentrations, and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of prospective cohort studies. Diabetes Care. 2021;44:2173–2181.
23. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr. 2010;91:535–546.
24. Chowdhury R, Warnakula S, Kunutsor S, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014;160:398–406.
25. de Souza RJ, Mente A, Maroleanu A, et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ. 2015;351:h3978.
26. Dehghan M, Mente A, Zhang X, et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet. 2017;390:2050–2062.
27. Dayton S, Pearce ML, Hashimoto S, Dixon WJ, Tomiyasu U. A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation. 1969;40(suppl II):II-1–II-63.
28. Leren P. The Oslo Diet-Heart Study: eleven-year report. Circulation. 1970;42:935–942.
29. Turpeinen O, Karvonen MJ, Pekkarinen M, Miettinen M, Elosuo R, Paavilainen E. Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study. Int J Epidemiol. 1979;8:99–118.
30. Research Committee to the Medical Research Council. Controlled trial of soya-bean oil in myocardial infarction. Lancet. 1968;2:693–699.
31. Ramsden CE, Zamora D, Leelarthaepin B, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ. 2013;346:e8707.
32. Ramsden CE, Zamora D, Majchrzak-Hong S, et al. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73). BMJ. 2016;353:i1246.
33. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010;7:e1000252.
34. Hooper L, Martin N, Jimoh OF, Kirk C, Foster E, Abdelhamid AS. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. 2020;8:CD011737.
35. Kitessa SM, Abeywardena MY. Lipid-induced insulin resistance in skeletal muscle: the chase for the culprit goes from total intramuscular fat to lipid intermediates, and finally to species of lipid intermediates. Nutrients. 2016;8(8):466.
36. Numao S, Kawano H, Endo N, Yamada Y, Konishi M, Takahashi M, Sakamoto S. Short-term low carbohydrate/high-fat diet intake increases postprandial plasma glucose and glucagon-like peptide-1 levels during an oral glucose tolerance test in healthy men. Eur J Clin Nutr. 2012;66(8):926–931.
37. Rosqvist F, Iggman D, Kullberg J, et al. Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans. Diabetes. 2014;63(7):2356–2368.
38. Himsworth HP. Dietetic factors influencing the glucose tolerance and the activity of insulin. J Physiol. 1934;81(1):29–48. (Animal confirmation of his earlier human work.)
39. Himsworth HP. Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. Lancet. 1936;227(5864):127–130.
40. Shomali M. Diabetes treatment in 2025: can scientific advances keep pace with prevalence? Ther Adv Endocrinol Metab. 2012;3(5):163–173.
41. Hall KD, Guo J, Courville AB, et al. Effect of a plant-based, low-fat diet versus an animal-based, ketogenic diet on ad libitum energy intake. Nat Med. 2021;27(2):344–353.
42. Hamley S. The effect of replacing saturated fat with mostly n-6 polyunsaturated fat on coronary heart disease: a meta-analysis of randomised controlled trials. Nutr J. 2017;16:30.
43. Sacks FM, Lichtenstein AH, Wu JHY, et al. Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association. Circulation. 2017;136:e1–e23.
44. Howard BV, Van Horn L, Hsia J, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women’s Health Initiative randomized controlled dietary modification trial. JAMA. 2006;295:655–666.
45. Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;378:e34.
46. Hooper L, Al-Khudairy L, Abdelhamid AS, et al. Omega-6 fats for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2018;11:CD011094.
47. Nordestgaard BG, Chapman MJ, Humphries SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013;34:3478–3490.
48. Ference BA, Yoo W, Alesh I, et al. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J Am Coll Cardiol. 2012;60:2631–2639.
49. Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459–2472.
50. Koch CA, Kjeldsen EW, Frikke-Schmidt R. Vegetarian or vegan diets and blood lipids: a meta-analysis of randomized trials. Eur Heart J. 2023;44(28):2609–2622.
51. Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376:1670–1681.
52. Cannon CP, Blazing MA, Giugliano RP, et al. Ezetimibe added to statin therapy after acute coronary syndromes (IMPROVE-IT). N Engl J Med. 2015;372:2387–2397.
53. Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease (FOURIER). N Engl J Med. 2017;376:1713–1722.
54. World Health Organization. Saturated Fatty Acid and Trans-Fatty Acid Intake for Adults and Children: WHO Guideline. Geneva: WHO; 2023.
55. Institute of Medicine (National Academies). Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC: National Academies Press; 2005.
56. Dietary Guidelines Advisory Committee. Scientific Report of the 2025 Dietary Guidelines Advisory Committee. US Department of Agriculture and US Department of Health and Human Services; December 2024.
57. US Department of Health and Human Services and US Department of Agriculture. Dietary Guidelines for Americans, 2025–2030. January 2026.
58. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Circulation. 2019;140:e596–e646.
59. Lichtenstein AH, Appel LJ, Vadiveloo M, et al. 2021 dietary guidance to improve cardiovascular health: a scientific statement from the American Heart Association. Circulation. 2021;144:e472–e487.
60. Evert AB, Dennison M, Gardner CD, et al. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care. 2019;42:731–754.
61. Rock CL, Thomson C, Gansler T, et al. American Cancer Society guideline for diet and physical activity for cancer prevention. CA Cancer J Clin. 2020;70:245–271.
62. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents (endorsed by the American Academy of Pediatrics). Summary report. Pediatrics. 2011;128(suppl 5):S213–S256.
63. Johnson SA, Kirkpatrick CF, Miller NH, et al. Saturated fat intake and the prevention and management of cardiovascular disease in adults: an Academy of Nutrition and Dietetics evidence-based nutrition practice guideline. J Acad Nutr Diet. 2023;123(12):1808–1830.
64. Raj S, Guest NS, Landry MJ, Mangels AR, Pawlak R, Rozga M. Vegetarian dietary patterns for adults: a position paper of the Academy of Nutrition and Dietetics. J Acad Nutr Diet. 2025;125(6):831–846. (Superseding, for all life stages, Melina V, Craig W, Levin S. Position of the Academy of Nutrition and Dietetics: vegetarian diets. J Acad Nutr Diet. 2016;116:1970–1980.)
65. American College of Lifestyle Medicine. Official dietary position statement: eating plans based predominantly on a variety of minimally processed vegetables, fruits, whole grains, legumes, nuts, and seeds. 2018.
66. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227–3337.
67. Scientific Advisory Committee on Nutrition (UK). Saturated Fats and Health. London: Public Health England; 2019.
68. Blomhoff R, Andersen R, Arnesen EK, et al. Nordic Nutrition Recommendations 2023. Copenhagen: Nordic Council of Ministers; 2023.
69. National Heart Foundation of Australia. Dietary Fats and Heart Healthy Eating: Position Statement and Evidence Paper. 2019.
70. Health Canada. Canada’s Dietary Guidelines for Health Professionals and Policy Makers. Ottawa; 2019.
71. World Cancer Research Fund / American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Cancer: A Global Perspective. Third Expert Report. 2018.
72. Johnson GH, Fritsche K. Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials. J Acad Nutr Diet. 2012;112:1029–1041.
73. Rett BS, Whelan J. Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: a systematic review. Nutr Metab (Lond). 2011;8:36.
74. Silvester KR, Bingham SA, Pollock JR, Cummings JH, O’Neill IK. Effect of meat and resistant starch on fecal excretion of apparent N-nitroso compounds and ammonia from the human large bowel. Nutr Cancer. 1997;29(1):13–23.
75. Harris WS, Mozaffarian D, Rimm E, et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association. Circulation. 2009;119:902–907.
76. Maki KC, Chen X, Wilcox ML, et al. Inverse associations of serum total omega-6 polyunsaturated fatty acids and linoleic acid with biomarkers of inflammation: a cross-sectional analysis. J Nutr. 2026;156(6):101471.
77. Petersen KS, Messina M, Flickinger B. Health implications of linoleic acid and seed oil intake. Nutr Today. 2026;61(1):19–25.
78. Miller M, Aggarwal M, Allen K, et al. A clinician’s guide for trending cardiovascular nutritional controversies in 2026. JACC Adv. 2026;5(3):102591.
79. Neelakantan N, Seah JYH, van Dam RM. The effect of coconut oil consumption on cardiovascular risk factors: a systematic review and meta-analysis of clinical trials. Circulation. 2020;141:803–814.
80. Diederichsen ACP, Lindholt JS, Möller S, et al. Vitamin K2 and D in patients with aortic valve calcification: a randomized double-blinded clinical trial. Circulation. 2022;145(18):1387–1397.
81. Fernandez ML, West KL. Mechanisms by which dietary fatty acids modulate plasma lipids. J Nutr. 2005;135(9):2075–2078.
82. Mustad VA, Etherton TD, Cooper AD, et al. Reducing saturated fat intake is associated with increased levels of LDL receptors on mononuclear cells in healthy men and women. J Lipid Res. 1997;38(3):459–468.
83. Krenek AM, Mathews A, Guo J, et al. Recipe for heart health: a randomized crossover trial on cardiometabolic effects of extra virgin olive oil within a whole-food plant-based vegan diet. J Am Heart Assoc. 2024;13(15):e035034.
84. Martinez Steele E, Baraldi LG, Louzada ML, Moubarac JC, Mozaffarian D, Monteiro CA. Ultra-processed foods and added sugars in the US diet: evidence from a nationally representative cross-sectional study. BMJ Open. 2016;6(3):e009892.
85. Lane MM, Gamage E, Du S, et al. Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses. BMJ. 2024;384:e077310.
86. Seah JY, Gay GM, Su J, et al. Consumption of red meat, but not cooking oils high in polyunsaturated fat, is associated with higher arachidonic acid status in Singapore Chinese adults. Nutrients. 2017;9(2):101.
87. Mustonen AM, Nieminen P. Dihomo-gamma-linolenic acid (20:3n-6): metabolism, derivatives, and potential significance in chronic inflammation. Int J Mol Sci. 2023;24(3):2116.
88. Commission Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods. Official Journal of the European Union; 2012.
89. Astrup A, Magkos F, Bier DM, et al. Saturated fats and health: a reassessment and proposal for food-based recommendations. J Am Coll Cardiol. 2020;76:844–857.
90. Nissen SE, Lincoff AM, Brennan D, et al. Bempedoic acid and cardiovascular outcomes in statin-intolerant patients (CLEAR Outcomes). N Engl J Med. 2023;388:1353–1364.

Last updated: September 29, 2026, 00:31 UTC.